Home / United States / Central Asia Lumeichun Biotech (ZYLMD)
Central Asia Lumeichun Biotech (ZYLMD)
No short position is open on this share today.
Open positions
No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Get the moves on Central Asia Lumeichun Biotech (ZYLMD) by mail.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | Shares sold short | End of publication |
|---|---|---|---|
| August 14, 2026 | Aggregated total | 78 shares |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in the United States
- Lucas GC Limited Ordinary Shar (LGCL) 61.62%
- Flash Sports & Media Holdings, (FLZH) 59.16%
- BTC Digital Ltd. Ordinary Shar (BTCT) 47.02%
- Wolfspeed, Inc. (WOLF) 46.50%
- Karyopharm Therapeutics Inc. C (KPTI) 43.27%
- Ondas Inc. Common Stock (ONDS) 39.71%
- Capricor Therapeutics, Inc. Co (CAPR) 38.16%
- Hertz Global Holdings, Inc Com (HTZ) 36.25%
- TruGolf Holdings, Inc. Class A (TRUG) 36.10%
- Serve Robotics Inc. Common Sto (SERV) 35.35%
- Nexera Technologies Ltd Ordina (NEXR) 35.00%
- LENZ Therapeutics, Inc. Common (LENZ) 34.61%
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Central Asia Lumeichun Biotech (ZYLMD), source FINRA, data as at August 14, 2026, https://www.quivad.com/action/central-asia-lumeichun-biotech-zylmd